Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 3 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2021 Filed Feb 17, 2021 22:38 UTC |
Alaix Juan RamonDirector
|
Tax withholdingCommon Stock | 19,920 | $166.71 | $3,320,863.20 |
DisclosureSEC source: 0001555280-21-000130 · wf-form4_161360152135046.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,833 Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:38 UTC |
Alaix Juan RamonDirector
|
Exercise / conversionCommon Stock | 37,528 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000130 · wf-form4_161360152135046.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:16 UTC |
Kelly Robert EdwardExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000100 · wf-form4_161351374187911.xml · derivative · entry 5 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,784 Underlying: Common Stock · 729 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F8 · derivative.exercise_price: 729 options granted March 4, 2014 at an exercise price of $30.89 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 9,022 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,010 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:16 UTC |
Kelly Robert EdwardExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 821 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000100 · wf-form4_161351374187911.xml · derivative · entry 4 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,513 Underlying: Common Stock · 821 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 821 options granted January 31, 2013 at an exercise price of $26.00 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 9,022 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,739 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:16 UTC |
Kelly Robert EdwardExecutive Vice President
|
SaleCommon Stock | 2,054 | $161.15 | $331,002.10 |
DisclosureSEC source: 0001555280-21-000100 · wf-form4_161351374187911.xml · nonDerivative · entry 3 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,704 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:16 UTC |
Kelly Robert EdwardExecutive Vice President
|
Exercise / conversionCommon Stock | 729 | $30.89 | $22,518.81 |
DisclosureSEC source: 0001555280-21-000100 · wf-form4_161351374187911.xml · nonDerivative · entry 2 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:16 UTC |
Kelly Robert EdwardExecutive Vice President
|
Exercise / conversionCommon Stock | 821 | $26.00 | $21,346.00 |
DisclosureSEC source: 0001555280-21-000100 · wf-form4_161351374187911.xml · nonDerivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:54 UTC |
MCCALLISTER MICHAEL BDirector
|
GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000075 · wf-form4_161317046355432.xml · derivative · entry 1 MCCALLISTER MICHAEL B · CIK 0001018657 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,473.7158 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,779.1458 RSUs will vest on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 18:02 UTC |
STEERE WILLIAM C JRDirector
|
GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000081 · wf-form4_161317091870623.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,473.7158 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,779.1458 RSUs will vest on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 18:20 UTC |
Pudloski Sherry NExecutive Vice President
|
GrantStock Option · Derivative | 3,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000092 · wf-form4_161317201696276.xml · derivative · entry 2 Pudloski Sherry N · CIK 0001806929 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,353 Underlying: Common Stock · 3,305 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 8,048 options granted March 31, 2020 at an exercise price of $117.69 per option; and 3,305 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 8,048 options granted March 31, 2020 at an exercise price of $117.69 per option; and 3,305 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 18:20 UTC |
Pudloski Sherry NExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 778 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000092 · wf-form4_161317201696276.xml · derivative · entry 1 Pudloski Sherry N · CIK 0001806929 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,914.0979 Underlying: Common Stock · 778 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,136.0979 RSUs will vest on March 31, 2023; and 778 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 17:59 UTC |
Reed Willie MDirector
|
GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000078 · wf-form4_161317072385708.xml · derivative · entry 1 Reed Willie M · CIK 0001601695 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,473.7158 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,779.1458 RSUs will vest on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:19 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 61,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000091 · wf-form4_161317195897395.xml · derivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,263 Underlying: Common Stock · 61,078 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 63,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 63,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:19 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
GrantRestricted Stock Unit · Derivative | 14,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000091 · wf-form4_161317195897395.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,762.4539 Underlying: Common Stock · 14,381 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 6,948.8824 RSUs will vest on February 13, 2021; 5,201.6369 RSUs will vest on February 12, 2022; 13,230.9346 RSUs will vest on February 11, 2023; and 14,381 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 17:56 UTC |
Norden GregoryDirector
|
GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000076 · wf-form4_161317055087379.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,473.7158 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,779.1458 RSUs will vest on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:01 UTC |
SCULLY ROBERT WDirector
|
GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000080 · wf-form4_161317085899970.xml · derivative · entry 1 SCULLY ROBERT W · CIK 0001352881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,473.7158 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,779.1458 RSUs will vest on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:47 UTC |
Bisaro PaulDirector
|
GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000071 · wf-form4_161317004477953.xml · derivative · entry 1 BISARO PAUL · CIK 0001237253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,473.7158 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,779.1458 RSUs will vest on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:57 UTC |
PARENT LOUISE MDirector
|
GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000077 · wf-form4_161317064139381.xml · derivative · entry 1 PARENT LOUISE M · CIK 0001209456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,473.7158 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,779.1458 RSUs will vest on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:49 UTC |
DAMELIO FRANK ADirector
|
GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000072 · wf-form4_161317012277154.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,473.7158 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,779.1458 RSUs will vest on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 17:59 UTC |
Rhodes LindaDirector
|
GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000079 · wf-form4_161317077936198.xml · derivative · entry 1 Rhodes Linda · CIK 0001336284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,473.7158 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,779.1458 RSUs will vest on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 17:50 UTC |
Sanjay KhoslaDirector
|
GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000073 · wf-form4_161317021253480.xml · derivative · entry 1 Sanjay Khosla · CIK 0001387531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,473.7158 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,779.1458 RSUs will vest on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:21 UTC |
Trawicki RomanExecutive Vice President
|
GrantStock Option · Derivative | 9,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000093 · wf-form4_161317207712772.xml · derivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,751 Underlying: Common Stock · 9,254 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:21 UTC |
Trawicki RomanExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 2,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000093 · wf-form4_161317207712772.xml · derivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,621.1353 Underlying: Common Stock · 2,179 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 3,705.5275 RSUs will vest on February 13, 2021; 3,467.7579 RSUs will vest on February 12, 2022; 2,268.8499 RSUs will vest on February 11, 2023; and 2,179 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:18 UTC |
Nayak Abhay UExecutive Vice President
|
GrantStock Option · Derivative | 2,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000090 · wf-form4_161317189860609.xml · derivative · entry 2 Nayak Abhay U · CIK 0001797754 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,283 Underlying: Common Stock · 2,478 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 1,147 options granted February 12, 2019 at an exercise price of $87.51 per option; 1,658 options granted February 11, 2020 at an exercise price of $144.03 per option; and 2,478 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 1,147 options granted February 12, 2019 at an exercise price of $87.51 per option; 1,658 options granted February 11, 2020 at an exercise price of $144.03 per option; and 2,478 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:18 UTC |
Nayak Abhay UExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 583 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000090 · wf-form4_161317189860609.xml · derivative · entry 1 Nayak Abhay U · CIK 0001797754 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,023.5434 Underlying: Common Stock · 583 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 1,760.0166 RSUs will vest on July 31, 2021; 288.3055 RSUs will vest on February 12, 2022; 392.2213 RSUs will vest on February 11, 2023; and 583 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:17 UTC |
McFarland James MichaelExecutive Vice President
|
GrantStock Option · Derivative | 2,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000089 · wf-form4_161317183994174.xml · derivative · entry 2 McFarland James Michael · CIK 0001801162 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,241 Underlying: Common Stock · 2,148 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 2,532 options granted February 19, 2016 at an exercise price of $41.83 per option; 1,934 options granted February 14, 2017 at an exercise price of $55.02 per option; 1,314 options granted February 13, 2018 at an exercise price of $73.24 per option; 918 options granted February 12, 2019 at an exercise price of $87.51 per option; 2,395 options granted February 11, 2020 at an exercise price of $144.03 per option; and 2,148 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 2,532 options granted February 19, 2016 at an exercise price of $41.83 per option; 1,934 options granted February 14, 2017 at an exercise price of $55.02 per option; 1,314 options granted February 13, 2018 at an exercise price of $73.24 per option; 918 options granted February 12, 2019 at an exercise price of $87.51 per option; 2,395 options granted February 11, 2020 at an exercise price of $144.03 per option; and 2,148 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:17 UTC |
McFarland James MichaelExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 505 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000089 · wf-form4_161317183994174.xml · derivative · entry 1 McFarland James Michael · CIK 0001801162 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,673.4095 Underlying: Common Stock · 505 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 370.5526 RSUs will vest on February 13, 2021; 230.6444 RSUs will vest on February 12, 2022; 567.2125 RSUs will vest on February 11, 2023; and 505 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:16 UTC |
Mamilli WafaaExecutive Vice President
|
GrantStock Option · Derivative | 6,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000088 · wf-form4_161317175907415.xml · derivative · entry 2 Mamilli Wafaa · CIK 0001800960 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,230 Underlying: Common Stock · 6,279 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 16,951 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,279 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 16,951 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,279 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:16 UTC |
Mamilli WafaaExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 1,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000088 · wf-form4_161317175907415.xml · derivative · entry 1 Mamilli Wafaa · CIK 0001800960 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,491.7321 Underlying: Common Stock · 1,478 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 4,013.7321 RSUs will vest on February 11, 2023; and 1,478 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:15 UTC |
Lagano RoxanneExecutive Vice President
|
GrantStock Option · Derivative | 7,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000087 · wf-form4_161317170553912.xml · derivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,704 Underlying: Common Stock · 7,106 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 7,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 7,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:15 UTC |
Lagano RoxanneExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 1,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000087 · wf-form4_161317170553912.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,476.7924 Underlying: Common Stock · 1,673 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 3,937.6321 RSUs will vest on February 13, 2021; 3,033.7825 RSUs will vest on February 12, 2022; 1,832.3778 RSUs will vest on February 11, 2023; and 1,673 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:14 UTC |
Knupp Catherine A.Executive Vice President
|
GrantStock Option · Derivative | 12,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000086 · wf-form4_161317162816766.xml · derivative · entry 2 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,266 Underlying: Common Stock · 12,063 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 13,266 options granted February 11, 2020 at an exercise price of $144.03 per option; and 12,063 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 13,266 options granted February 11, 2020 at an exercise price of $144.03 per option; and 12,063 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:14 UTC |
Knupp Catherine A.Executive Vice President
|
GrantRestricted Stock Unit · Derivative | 2,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000086 · wf-form4_161317162816766.xml · derivative · entry 1 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,132.3131 Underlying: Common Stock · 2,840 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 6,948.8824 RSUs will vest on February 13, 2021; 5,201.6369 RSUs will vest on February 12, 2022; 3,141.7938 RSUs will vest on February 11, 2023; and 2,840 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:13 UTC |
Kelly Robert EdwardExecutive Vice President
|
GrantStock Option · Derivative | 6,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000085 · wf-form4_161317156891689.xml · derivative · entry 2 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,334 Underlying: Common Stock · 6,610 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 9,843 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,739 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 9,843 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,739 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:13 UTC |
Kelly Robert EdwardExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 1,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000085 · wf-form4_161317156891689.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,920.2182 Underlying: Common Stock · 1,556 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 926.3818 RSUs will vest on February 13, 2021; 866.9394 RSUs will vest on February 12, 2022; 1,570.8970 RSUs will vest on February 11, 2023; and 1,556 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:12 UTC |
David GlennChief Financial Officer
|
GrantStock Option · Derivative | 18,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000084 · wf-form4_161317151455703.xml · derivative · entry 2 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,795 Underlying: Common Stock · 18,326 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option; 18,794 options granted February 11, 2020 at an exercise price of $144.03 per option; and 18,326 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option; 18,794 options granted February 11, 2020 at an exercise price of $144.03 per option; and 18,326 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:12 UTC |
David GlennChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 4,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000084 · wf-form4_161317151455703.xml · derivative · entry 1 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,391.5178 Underlying: Common Stock · 4,315 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 7,412.0733 RSUs will vest on February 13, 2021; 6,213.2347 RSUs will vest on February 12, 2022; 4,451.2098 RSUs will vest on February 11, 2023; and 4,315 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:11 UTC |
Chen Heidi C.Executive Vice President
|
GrantStock Option · Derivative | 8,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000083 · wf-form4_161317145688004.xml · derivative · entry 2 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,627 Underlying: Common Stock · 8,758 shares Expires not disclosed F6 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 8,758 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 8,758 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:11 UTC |
Chen Heidi C.Executive Vice President
|
GrantRestricted Stock Unit · Derivative | 2,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000083 · wf-form4_161317145688004.xml · derivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,414.1181 Underlying: Common Stock · 2,062 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 5,327.2049 RSUs will vest on February 13, 2021; 3,756.0633 RSUs will vest on February 12, 2022; 2,268.8499 RSUs will vest on February 11, 2023; and 2,062 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:10 UTC |
Bettington Timothy JExecutive Vice President
|
GrantStock Option · Derivative | 6,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000082 · wf-form4_161317138142925.xml · derivative · entry 2 Bettington Timothy J · CIK 0001797894 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,243 Underlying: Common Stock · 6,610 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:10 UTC |
Bettington Timothy JExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 1,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000082 · wf-form4_161317138142925.xml · derivative · entry 1 Bettington Timothy J · CIK 0001797894 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,126.897 Underlying: Common Stock · 1,556 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 1,570.8970 RSUs will vest on February 11, 2023; and 1,556 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:52 UTC |
Leatherberry Antoinette ReneeDirector
|
GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000074 · wf-form4_161317030081940.xml · derivative · entry 1 Leatherberry Antoinette Renee · CIK 0001834624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,879.2129 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 1,448.2129 RSUs will vest on December 8, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:46 UTC |
Alaix Juan RamonDirector
|
GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000070 · wf-form4_161316998998299.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,702.722 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 37,528.6472 RSUs will vest on February 13, 2021; 27,743.0748 RSUs will vest on February 12, 2022; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:11 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
GrantPerformance Award Unit · Derivative | 10,145.4088 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000040 · wf-form4_161308509096630.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,145.4088 Underlying: Common Stock · 10,145.4088 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2018-2020 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:13 UTC |
Trawicki RomanExecutive Vice President
|
GrantPerformance Award Unit · Derivative | 5,409.6632 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000042 · wf-form4_161308518363274.xml · derivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,409.6632 Underlying: Common Stock · 5,409.6632 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2018-2020 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:09 UTC |
McFarland James MichaelExecutive Vice President
|
GrantPerformance Award Unit · Derivative | 539.541 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000038 · wf-form4_161308494800838.xml · derivative · entry 1 McFarland James Michael · CIK 0001801162 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539.541 Underlying: Common Stock · 539.541 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2018-2020 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:07 UTC |
Lagano RoxanneExecutive Vice President
|
GrantPerformance Award Unit · Derivative | 5,747.6396 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000036 · wf-form4_161308486296983.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,747.6396 Underlying: Common Stock · 5,747.6396 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2018-2020 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:06 UTC |
Knupp Catherine A.Executive Vice President
|
GrantPerformance Award Unit · Derivative | 10,145.4088 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000034 · wf-form4_161308477322443.xml · derivative · entry 1 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,145.4088 Underlying: Common Stock · 10,145.4088 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2018-2020 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:03 UTC |
Kelly Robert EdwardExecutive Vice President
|
GrantPerformance Award Unit · Derivative | 1,351.9068 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000032 · wf-form4_161308460837183.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,351.9068 Underlying: Common Stock · 1,351.9068 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2018-2020 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:00 UTC |
David GlennChief Financial Officer
|
GrantPerformance Award Unit · Derivative | 10,821.3626 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000030 · wf-form4_161308442599304.xml · derivative · entry 1 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,821.3626 Underlying: Common Stock · 10,821.3626 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2018-2020 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.